New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
View Older Stories View More Recent Stories
-
Merge Named to Forbes List of America’s Best Startup Employers 2024 For Second Consecutive Year
-
Acrivon Therapeutics Appoints Santhosh Palani, Ph.D., CFA, Experienced Board Member and Healthcare Investor, to its Board of Directors
-
Form SC 13D/A GLYCOMIMETICS INC Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
FIRE1 Completes Enrollment in U.S. Early Feasibility Study of Innovative Remote Heart Failure Monitoring System
-
CrewLAB Raises $1.6M to Democratize Data & Technology for Endurance Sports Teams
-
Merge Announces its Availability in AWS Marketplace
-
Form SC 13G Sagimet Biosciences Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Form SC 13G/A Inozyme Pharma, Inc. Filed by: New Enterprise Associates 15, L.P.
-
Form SC 13G/A Coursera, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Merge Reports Record Customer Growth in 2023 with 60% Increase in New Customer Logos
-
Form SC 13D/A GLYCOMIMETICS INC Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
Everside Health and Marathon Health Announce Merger to Meet Accelerating Employer Demand for Advanced Primary Care Services
-
MBX Biosciences Appoints Steven Ryder, M.D., to Board of Directors
-
Form 4 Sagimet Biosciences Inc. For: Jan 29 Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
MBX Biosciences to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference
-
Springbig announces changes in its board of directors following the completion of its $8.0 million debt financing with a syndicate of lenders
-
OHAI.AI LAUNCHES AI VIRTUAL ASSISTANT TO REVOLUTIONIZE HOME AND PERSONAL ORGANIZATION IN SUPPORT OF CHIEF HOUSEHOLD OFFICERS
-
ORIC Pharmaceuticals (ORIC) Prices 12.5M Share Offering at $10/sh
-
ORIC Pharmaceuticals Announces $125 Million Private Placement Financing
-
Comanche Biopharma Closes Oversubscribed $75 Million Series B Financing to Advance Mission to Develop and Make Globally Available the First Treatment Targeting a Root Cause of Preeclampsia
-
NEA Welcomes Tiffany Luck as Partner on Its Technology Investing Team
-
Sunrise AI Secures Pre-Seed Funding Led by Andrew Ng's AI Fund
-
Boisson Announces Further Expansion of National Wholesale Distribution to Disrupt the $550M Non-Alcoholic Beverage Industry
-
Form SC 13D/A Mirum Pharmaceuticals, Filed by: New Enterprise Associates 16, L.P.
-
ClearMotion to supply smooth suspension tech for Nio's ET9 EV
-
Form SC 13D/A Bright Health Group Inc. Filed by: New Enterprise Associates 15, L.P.
-
MBX Biosciences to Participate in 42nd Annual J.P. Morgan Healthcare Conference
-
ACA Has Helped Cut Independent Worker Uninsured Rate Nearly in Half, Yet Many Remain Without Health Coverage Due to Perceived Unaffordability
-
VAST Data Closes Series E Funding Round, Nearly Triples Valuation to $9.1 Billion
-
VAST Data eyes IPO after valuation surges to $9.1 billion in latest fund raise
-
New Report Reveals that 83% of Companies are Prioritizing Product Integrations in 2024
-
SpyGlass Pharma Strengthens Leadership to Further Advance its Intraocular Drug Delivery Platform
-
Sara Nayeem, M.D., Experienced Biopharmaceutical Venture Investor, Joins Enavate Sciences as Executive Vice President, Investments
-
Smartcar and Uber Partner to Accelerate the Transition to Electric by Removing Range Anxiety for Drivers
-
Second Front Systems raises $40 million, led by NEA, to speed delivery of commercial software to global public sector
-
Form SC 13D Korro Bio, Inc. Filed by: New Enterprise Associates 17, L.P.
-
Care.com and Stride Team Up to Provide Caregivers Access to Health Insurance and Other Benefits
-
Stride Health Partners with Shipt to Offer Shoppers and Drivers Access to Affordable Health Insurance During Open Enrollment
-
MBX Biosciences to Participate in Piper Sandler 35th Annual Healthcare Conference
-
Revelle Aesthetics Receives First International Clearance in Australia for its Avéli® Cellulite Device
-
Myna Snacks Launches to Bring Health, Flavor, and Fun to Snacking in the Digital Age
-
Aigen's $12M Series A Unleashes True-Solar Agriculture Robots
-
LXA Raises US$10M in Seed Funding Round Led by NEA
-
Form 3 Korro Bio, Inc. For: Nov 03 Filed by: New Enterprise Associates 17, L.P.
-
AviadoBio Announces FDA IND Clearance and Fast Track Designation for AVB-101 for the Treatment of Frontotemporal Dementia with Progranulin (GRN) Mutations
-
Timescale Launches Dynamic PostgreSQL, the Cost-Effective Alternative to Serverless and Peak-Allocation Pay Models
-
MBX Biosciences Announces Appointment of Michelle Graham as Chief Human Resources Officer
-
MBX Biosciences to Participate in Stifel 2023 Healthcare Conference
-
Stride Health Kicks Off 2024 ACA Open Enrollment with New Plan Selection Experience and New Partners
-
Insurtech startup QuoteWell comes out of stealth, raised over $20M in Series A funding led by NEA

